PharmaState Is Official Media Partner For DUPHAT 2022. Click the banner to explore more...spot_imgspot_imgspot_img

FDA – New Drug Approvals from 2009 to 2018

-

Total New Drugs were approved by FDA in last 10 years – 356

The maximum number of New Drug Approvals – In 2018 with a total 59 New Drugs Approved.

Average number of Drugs approved in last 10 years – 33 per year     

Source: FDA – CDER

FDA – New Drug Approvals for 2018

No. Drug 
Name
Active
Ingredient
Approval
 Date
FDA-approved use on
approval date
59 Ultomiris ravulizumab 12/21/2018 To treat paroxysmal
nocturnal
 hemoglobinuria (PNH)
58 Elzonris tagraxofusp-erzs 12/21/2018 To treat blastic
plasmacytoid dendritic
cell neoplasm (BPDCN)
57 Asparlas calaspargase pegol-mknl 12/20/2018 To treat acute
lymphoblastic leukemia (ALL)
in pediatric and
young adult patients age
1 month to 21 years
56 Motegrity prucalopride 12/14/2018 To treat chronic
idiopathic constipation
55 Xospata gilteritinib 11/28/2018 To treat patients
who have relapsed or
refractory acute
myeloid leukemia (AML)
54 Firdapse amifampridine 11/28/2018 To treat  Lambert-Eaton
myasthenic
syndrome (LEMS) in adults
53 Vitrakvi larotrectinib 11/26/2018 To treat patients
 whose cancers
have a specific
genetic feature (biomarker)
52 Daurismo glasdegib 11/21/2018 To treat newly-diagnosed
acute myeloid
 leukemia (AML) in
adult patients
 
51 Gamifant emapalumab-lzsg 11/20/2018 To treat primary
hemophagocytic
lymphohistiocytosis (HLH) 
50 Aemcolo rifamycin 11/16/2018 To treat travelers’ diarrhea
49 Yupelri revefenacin 11-08-2018 To treat patients with
chronic obstructive
pulmonary disease (COPD)
48 Lorbrena lorlatinib 11-02-2018 To treat patients with
anaplastic lymphoma
 kinase (ALK)-positive
metastatic non-small cell lung
cancer
47 Xofluza baloxavir marboxil 10/24/2018 For the treatment of acute
uncomplicated influenza in
patients who have been
symptomatic for no more
than 48 hours. 
46 Talzenna talazoparib 10/16/2018 For the treatment of locally
advanced or metastatic
breast cancer patients with a
germline BRCA mutation. 
 
45 Tegsedi inotersen 10-05-2018 To treat polyneuropathy
of hereditary
transthyretin-mediated
amyloidosis in adults
44 Revcovi elapegademase-lvlr 10-05-2018 To treat Adenosine
Deaminase-Severe Combined
Immunodeficiency (ADA-SCID)
43 Nuzyra omadacycline 10-03-2018 To treat community-acquired
 bacterial pneumonia
and acute bacterial skin
 and skin structure infections
42 Seysara sarecycline 10-01-2018 To treat inflammatory
lesions of non-nodular
 moderate to severe
acne vulgaris in patients
 9 years of age and older
41 Libtayo cemiplimab-rwlc 9/28/2018 To treat cutaneous squamous
cell carcinoma (CSCC) 
40 Vizimpro dacomitinib 9/27/2018 To treat metastatic
non-small-cell lung cancer
39 Emgality galcanezumab-gnlm 9/27/2018 For the preventive 
 treatment of migraine
 in adults
38 Copiktra duvelisib 9/24/2018 To treat relapsed or
refractory chronic
lymphocytic leukemia,
 small lymphocytic lymphoma
and follicular lymphoma
37 Ajovy fremanezumab-vfrm 9/14/2018 For the preventive treatment of migraine in adults
36 Lumoxiti moxetumomab pasudotox-tdfk 9/13/2018 To treat hairy cell leukemia
35 Pifeltro doravirine 8/30/2018 To treat HIV-1 infection
in adult patients
34 Xerava eravacycline 8/27/2018 To treat complicated
intra-abdominal infections in
 patients 18 years of
age and older
33 Takhzyro lanadelumab 8/23/2018 To treat types I and II
 hereditary angioedema
32 Oxervate cenegermin-bkbj 8/22/2018 To treat neurotrophic keratitis
31 Diacomit stiripentol 8/20/2018 To treat seizures associated
with Dravet syndrome in
patients 2 years of age and
 older taking clobazam
 
30 Galafold migalastat 08-10-2018 To treat treat adults with
Fabry disease. 
29 Annovera segesterone acetate
 and ethinyl estradiol
vaginal system
08-10-2018 New vaginal ring used to
prevent pregnancy
 for an entire year 
28 Onpattro patisiran 08-10-2018 To treat the polyneuropathy
of hereditary
 transthyretin-mediated
 amyloidosis in adult patients
27 Poteligeo mogamulizumab-kpkc 08-08-2018 To treat two rare types
of non-Hodgkin lymphoma
26 Mulpleta lusutrombopag 7/31/2018 To treat thrombocytopenia
 in adult patients with
chronic liver disease who
are scheduled to
 undergo a procedure
25 Omegaven fish oil triglycerides 7/27/2018 As a source of calories and
 fatty acids in pediatric patients with parenteral nutrition-associated cholestasis
24 Orilissa elagolix sodium 7/23/2018 For the management of
moderate to severe pain
 associated with endometriosis
23 Krintafel tafenoquine 7/20/2018 For the radical
cure (prevention of relapse)
of Plasmodium vivax malaria
22 Tibsovo ivosidenib 7/20/2018 To treat patients with
relapsed or refractory
acute myeloid leukemia 
21 TPOXX tecovirimat 7/13/2018 To treat smallpox
20 Braftovi encorafenib 6/27/2018 To treat unresectable
or metastatic melanoma 
19 Mektovi binimetinib 6/27/2018 To treat unresectable or
metastatic melanoma 
18 Zemdri plazomicin 6/25/2018 To treat adults with
complicated urinary
tract infections
17 Epidiolex cannabidiol 6/25/2018 To treat rare, severe
forms of epilepsy
16 Moxidectin moxidectin 6/13/2018 To treat onchocerciasis
due to Onchocerca
volvulus in patients
aged 12 years and older
15 Olumiant baricitinib 5/31/2018 To treat moderately to
 severely active
rheumatoid arthritis
14 Palynziq pegvaliase-pqpz 5/24/2018 To treat adults with a
rare and serious genetic
disease known as
phenylketonuria (PKU)
13 Doptelet avatrombopag 5/21/2018 To treat low blood
 platelet count
(thrombocytopenia) in
 adults with chronic liver disease
who are scheduled to undergo
a medical or dental procedure
12 Lokelma sodium zirconium
cyclosilicate
5/18/2018 To treat hyperkalemia
11 Aimovig erenumab-aooe 5/17/2018 For the preventive treatment
for migraine
10 Lucemyra lofexidine hydrochloride 5/16/2018 For the non-opioid treatment
 for management of opioid
withdrawal symptoms in adults
9 Akynzeo fosnetupitant and
palonosetron
4/19/2018 To prevent acute and delayed
 nausea and vomiting
associated with initial and
repeat courses of highly
emetogenic cancer
chemotherapy
8 Crysvita burosumab-twza 4/17/2018 To treat adults and children
ages 1 year and older with
x-linked hypophosphatemia
(XLH), a rare,
inherited form of rickets
7 Tavalisse fostamatinib 4/17/2018 To treat thrombocytopenia
 in adult patients with
 persistent or chronic
 immune
thrombocytopenia (ITP)
6 Ilumya tildrakizumab 3/20/2018 To treat adults with
 moderate-to-severe plaque
 psoriasis who are candidates
 for systemic therapy
or phototherapy
5 Trogarzo ibalizumab-uiyk 03-06-2018 To treat HIV patients who
have limited treatment options
4 Erleada apalutamide 2/14/2018 To treat a certain type of
 prostate cancer using
novel clinical trial endpoint
3 Symdeko tezacaftor; ivacaftor 2/13/2018 To treat cystic fibrosis
in patients age
12 years and older
2 Biktarvy bictegravir,
embitcitabine,
tenofovir alafenamide
02-07-2018 To treat infection in
adults who have no
antiretroviral treatment
history or to replace the
 current antiretroviral regimen
1 Lutathera lutetium Lu 177 dotatate 1/26/2018 To treat a type of cancer that
affects the pancreas or
 gastrointestinal tract called
gastroenteropancreatic
 neuroendocrine
tumors (GEP-NETs).

Reference: USFDA

For any Feedback or suggestion mail at: info@pharmastate.com

PharmaState Blog
This is a platform for people working in the pharmaceuticals industry for Discussions, Jobs, News updates, Professional Profile display space and company business pages. PharmaState DNA is having four pillars: Quality, Transparency, Innovation & Benchmarks.

Share this article

Recent posts

Popular categories

Leave a Reply

Recent comments

Business Alnavedic on History of Indian Pharma Industry
Ahmed Mohamed Elkhodragy on MACO Calculation
Jennifer Osunde on DEFECTS IN UNCOATED TABLETS
Vinod on DEVIATION
Rajib ghose on TOOLING FOR TABLETING
K. SRinivasula Reddy on Quality Agreements – PART 2
Sunil Kumar M on SITE ACCEPTANCE TEST (SAT)
Khalid on IQ Protocol
Khalid on IQ Protocol
Nagabooshanam on Calibration of Reactor
PharmaState Blog on SOP for Sampling
Swapnil Khodake on TOOLING FOR TABLETING
%d bloggers like this: